Human Metapneumovirus Infections Following Hematopoietic Cell Transplantation: Factors Associated With Disease Progression
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human Metapneumovirus Infections Following Hematopoietic Cell Transplantation: Factors Associated With Disease Progression
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 63, Issue 2, Pages 178-185
Publisher
Oxford University Press (OUP)
Online
2016-05-04
DOI
10.1093/cid/ciw284
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies
- (2015) S. Seo et al. BLOOD
- New Approaches for Immunization and Therapy against Human Metapneumovirus
- (2015) Sherry C. Wen et al. Clinical and Vaccine Immunology
- Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial
- (2015) M. Mielcarek et al. HAEMATOLOGICA
- Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial
- (2015) M. Mielcarek et al. HAEMATOLOGICA
- Parainfluenza Virus Lower Respiratory Tract Disease After Hematopoietic Cell Transplant: Viral Detection in the Lung Predicts Outcome
- (2014) Sachiko Seo et al. CLINICAL INFECTIOUS DISEASES
- Paediatric human metapneumovirus infection: Epidemiology, prevention and therapy
- (2014) Nicola Principi et al. JOURNAL OF CLINICAL VIROLOGY
- Mortality Rates of Human Metapneumovirus and Respiratory Syncytial Virus Lower Respiratory Tract Infections in Hematopoietic Cell Transplantation Recipients
- (2013) Christian Renaud et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Outcome of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Hematopoietic Cell Transplant Recipients Receiving Aerosolized Ribavirin: Significance of Stem Cell Source and Oxygen Requirement
- (2013) Sachiko Seo et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Respiratory Syncytial Virus Lower Respiratory Disease in Hematopoietic Cell Transplant Recipients: Viral RNA Detection in Blood, Antiviral Treatment, and Clinical Outcomes
- (2013) Alpana Waghmare et al. CLINICAL INFECTIOUS DISEASES
- Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections
- (2013) D. P. Shah et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease
- (2013) Yae-Jean Kim et al. JOURNAL OF INFECTIOUS DISEASES
- Fatal human metapneumovirus infection following allogeneic hematopoietic stem cell transplantation
- (2013) C. Dokos et al. Transplant Infectious Disease
- Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation
- (2012) A. Egli et al. INFECTION
- Human Metapneumovirus: Lessons Learned over the First Decade
- (2011) V. Schildgen et al. CLINICAL MICROBIOLOGY REVIEWS
- Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients
- (2011) Christian Renaud et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients
- (2009) F. Milano et al. BLOOD
- Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin
- (2009) Denise Bonney et al. BRITISH JOURNAL OF HAEMATOLOGY
- Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients
- (2009) J. Kuypers et al. Transplant Infectious Disease
- Frequency of human metapneumovirus infection in hematopoietic SCT recipients during 3 consecutive years
- (2008) R R Oliveira et al. BONE MARROW TRANSPLANTATION
- Immune modulatory activity of ribavirin for serious human metapneumovirus disease: early i.v. therapy may improve outcomes in immunosuppressed SCT recipients
- (2008) A Safdar BONE MARROW TRANSPLANTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now